Liposomal-delivery of phosphodiesterase 5 inhibitors augments UT-15C-stimulated ATP release from human erythrocytes()

The use of liposomes to affect targeted delivery of pharmaceutical agents to specific sites may result in the reduction of side effects and an increase in drug efficacy. Since liposomes are delivered intravascularly, erythrocytes, which constitute almost half of the volume of blood, are ideal target...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowles, Elizabeth A., Feys, Dimitri, Ercal, Nuran, Sprague, Randy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613235/
https://www.ncbi.nlm.nih.gov/pubmed/28955799
http://dx.doi.org/10.1016/j.bbrep.2017.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613235/
https://www.ncbi.nlm.nih.gov/pubmed/28955799
http://dx.doi.org/10.1016/j.bbrep.2017.09.002

Ejemplares similares